🇺🇸 entecavir tablets in United States

62 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. White Blood Cell Count Decreased — 10 reports (16.13%)
  2. Neutrophil Count Decreased — 9 reports (14.52%)
  3. Anaemia — 8 reports (12.9%)
  4. Platelet Count Decreased — 7 reports (11.29%)
  5. Myelosuppression — 6 reports (9.68%)
  6. Death — 5 reports (8.06%)
  7. Hypokalaemia — 5 reports (8.06%)
  8. Alanine Aminotransferase Increased — 4 reports (6.45%)
  9. Hypoalbuminaemia — 4 reports (6.45%)
  10. Lymphocyte Count Decreased — 4 reports (6.45%)

Source database →

entecavir tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is entecavir tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for entecavir tablets in United States?

Sunshine Lake Pharma Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.